A randomized placebo-controlled pilot trial shows that intranasal vasopressin improves social deficits in children with autism
Karen J. Parker(Stanford University), Antonio Y. Hardan(Stanford University), Dean S. Carson(Stanford University), Noreen Mohsin(Cleveland Clinic), Debra S. Karhson(Stanford University), Joseph P. Garner(Stanford University), Jennifer M. Phillips(Stanford University), Jacqueline E. Summers(Stanford University), Lawrence K. Fung(Stanford University), Kyle Hinman(Stanford University), Raena D. Sumiyoshi(Stanford University), Kara S. Motonaga(Stanford University), Robin A. Libove(Stanford University), Ozge Oztan(Stanford University)
Cited by 190
Related Papers
Oxytocin receptor gene polymorphism (rs2254298) interacts with familial risk for psychopathology to predict symptoms of depression and anxiety in adolescent girls
|Psychoneuroendocrinology|2010|211
Clinical and genetic study of hereditary spastic paraplegia in Canada
|Neurology Genetics|2016|98
Acne treatment review and future perspectives
|Dermatologic Therapy|2022|70
Merkel cell carcinoma: An updated review of pathogenesis, diagnosis, and treatment options
|Dermatologic Therapy|2021|57
Lichen Simplex Chronicus Itch: An Update
|Acta Dermato Venereologica|2022|46